RopesTalk
By Ropes & Gray LLP
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Ropes & Gray LLP
Category: Business News
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 5
Reviews: 0
Episodes: 458
Description
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
| Episode | Date |
|---|---|
|
Multidimensional Data Reversion: Free Text Isn't Free
|
May 28, 2025 |
|
Navigating the SEC's New Marketing Rule FAQ Guidance
|
May 27, 2025 |
|
Culture & Compliance Chronicles: Emotionally Charged Leadership with Dina Denham Smith
|
May 14, 2025 |
|
Non-binding Guidance | Talkin' Trade: Trends in False Advertising and Related Competitor Disputes Involving FDA-Regulated Products
|
May 08, 2025 |
|
R&G Tech Studio: AI Innovation vs. Safety—Insights on a New Executive Order
|
May 07, 2025 |
|
Multidimensional Data Reversion: Harnessing Analytics and Visualization
|
Apr 30, 2025 |
|
R&G Tech Studio: Navigating AI Literacy—Understanding the EU AI Act
|
Apr 29, 2025 |
|
Getting Your Head Around the UK’s New (and Globally Relevant) “Failure to Prevent Fraud” Offence
|
Apr 22, 2025 |
|
Real World; Real Problems—First Steps in Addressing Real Estate Partnership Disputes
|
Apr 17, 2025 |
|
Culture & Compliance Chronicles: The Power of Business Compliance Ambassadors with Alexandra Belmonte
|
Apr 16, 2025 |
|
R&G Dugout: Navigating NIL—The Future of College Athletics and Investments
|
Apr 01, 2025 |
|
Multidimensional Data Reversion: E-Discovery Evolution—From Paper Trails to AI
|
Mar 26, 2025 |
|
Navigating Whistleblower Trends and Risk Mitigation Under a New Administration
|
Mar 25, 2025 |
|
Women @ RopesTalk: Conversation with Jan Sbarbaro, Lyric
|
Mar 19, 2025 |
|
Culture & Compliance Chronicles: Organizational Growth Through Fostering Speaking Out and Listening Up with Megan Reitz
|
Mar 12, 2025 |
|
Talkin' Trade: Section 337 Domestic Industry Shake-Up—Exploring the Lashify Decision
|
Mar 11, 2025 |
|
Alumni @ RopesTalk: DeepSeek Deep Dive with Dr. Vasanth Sarathy, Tufts University
|
Feb 26, 2025 |
|
Women @ RopesTalk: Conversation with Katy Motiey, Extreme Networks
|
Feb 19, 2025 |
|
Antitrust Insights: New HSR Rules Now in Effect
|
Feb 13, 2025 |
|
Culture & Compliance Chronicles: How Cultural Understanding Empowers Compliance with Tal Freilich
|
Feb 12, 2025 |
|
Controlling Opinions: The Outlook for Controlled Substances in 2025
|
Feb 11, 2025 |
|
R&G Dugout: Show Me the Money—Fund Formation & Management
|
Jan 22, 2025 |
|
Culture & Compliance Chronicles: Bridging and Cultures—Contextualizing Global Compliance with Letitia Adu-Ampoma
|
Jan 15, 2025 |
|
Antitrust Insights: New HSR Rules—Impacts to the Pharma Industry
|
Dec 16, 2024 |
|
Welcome to the R&G Dugout: Sports Investing—It's a Whole New Ballgame
|
Dec 12, 2024 |
|
Culture & Compliance Chronicles: Building a Culture of Fairness and Transparency with Danny Mayhew of Sanofi
|
Dec 11, 2024 |
|
A Word for Our Sponsors: GP-Led Secondary Perceptions Report with Campbell Lutyens
|
Dec 10, 2024 |
|
Health Care Transaction Laws Unwrapped: Recent Antitrust Developments
|
Dec 03, 2024 |
|
Non-binding Guidance: Clinical Trial Diversity in Focus
|
Nov 19, 2024 |
|
Controlling Opinions: Navigating DEA Diversion Investigations
|
Nov 18, 2024 |
|
Culture & Compliance Chronicles: Innovative Compliance Strategies with Katie Daniels
|
Nov 14, 2024 |
|
Women @ RopesTalk: Conversation with Veronica Lei, Eli Lilly
|
Nov 13, 2024 |
|
Health Care Transaction Laws Unwrapped: Deal Impacts for Private Equity Firms, MSOs & DSOs
|
Nov 12, 2024 |
|
California Law for Asset Managers: Navigating Noncompete Statutes & Workplace Violence Prevention Plans
|
Oct 31, 2024 |
|
Health Care Transaction Laws Unwrapped: Recent Developments on the West Coast
|
Oct 29, 2024 |
|
Non-binding Guidance: The Demise of Chevron and Implications for Future APA Challenges
|
Oct 22, 2024 |
|
Culture & Compliance Chronicles: Navigating Ethical Dilemmas and Building Trust with Dr. Brennan Jacoby
|
Oct 17, 2024 |
|
R&G Tech Studio Presents: Venture Capital and Emerging Companies Partner Raj Banerjee
|
Oct 16, 2024 |
|
Health Care Transaction Laws Unwrapped: Recent Developments on the East Coast
|
Oct 15, 2024 |
|
Talkin' Trade: Navigating the Post-Loper Bright World at the ITC
|
Oct 08, 2024 |
|
Culture & Compliance Chronicles Special: "Live" Edition: Voices from Across the Compliance Community on Culture
|
Oct 03, 2024 |
|
Health Care Transaction Laws Unwrapped: Recent Developments in the Midwest
|
Oct 01, 2024 |
|
Women @ RopesTalk: Conversation with Laura Berner, TRex Bio
|
Sep 18, 2024 |
|
Alumni @ RopesTalk: Board Service Insights with Alums Jennifer Borggaard & Robert Shapiro
|
Sep 17, 2024 |
|
Health Care Transaction Laws Unwrapped: Navigating Expanding Government Oversight of Health Care Investments
|
Sep 17, 2024 |
|
R&G Tech Studio Presents: IP Litigation Counsel Rachael Bacha
|
Sep 16, 2024 |
|
Culture & Compliance Chronicles: How Corporate Culture Drives Investment and Performance Outcomes
|
Sep 10, 2024 |
|
Interval and Tender Offer Funds for Private Fund Managers
|
Aug 29, 2024 |
|
A Word for Our Sponsors: GP-Led Secondaries Outlook with Devon Park Advisors (Part II)
|
Aug 28, 2024 |
|
A Word for Our Sponsors: GP-Led Secondaries Outlook with Devon Park Advisors (Part I)
|
Aug 15, 2024 |
|
R&G Tech Studio Presents: IP Litigation Counsel Matthew Shapiro
|
Aug 14, 2024 |
|
Culture & Compliance Chronicles: The FEPA Factor—Will the DOJ's Latest Tool Reshape the Landscape of Anti-Corruption Enforcement and Compliance?
|
Aug 13, 2024 |
|
Women @ RopesTalk: Conversation with Neena Reddy, Blue Owl Capital
|
Aug 07, 2024 |
|
Non-binding Guidance: How Drug and Device Companies Can Tackle Internet Misinformation
|
Aug 01, 2024 |
|
Controlling Opinions: Latest Developments Regarding Controlled Substance Issues in Telemedicine
|
Jul 29, 2024 |
|
Decoding Digital Health: Artificial Intelligence Unveiled—The Science Behind AI
|
Jul 25, 2024 |
|
California Privacy Laws for Asset Managers
|
Jul 23, 2024 |
|
Culture & Compliance Chronicles: A Journey into Team Ethical Culture with Guillem Casoliva Cabana
|
Jul 16, 2024 |
|
SCOTUS and the Future of the Administrative State: After Jarkesy and Loper Bright
|
Jul 12, 2024 |
|
Decoding Digital Health: Conversation with Dr. Bernardo Bizzo, Mass General Brigham AI
|
Jul 11, 2024 |
|
The Data Day: Recent Developments in AI Governance and State Privacy Laws
|
Jul 10, 2024 |
|
Non-binding Guidance: FDA Regulatory & Enforcement Risks Relevant to Academic Medical Centers, Health Systems and Research Institutions
|
Jun 28, 2024 |
|
A New Wave of ERISA Class Actions?: Some Employer/Fiduciary Implications of Lewandowski v. Johnson & Johnson
|
Jun 25, 2024 |
|
Alumni @ RopesTalk: Conversation with Charles Soule, Comic Book Writer & Novelist
|
Jun 24, 2024 |
|
Hospital and Health System Value-Based Care Strategy Update: Lightning Round with Practitioners in the Trenches
|
Jun 20, 2024 |
|
Asset Management Transatlantic Regulatory Roundup: Differences in SEC and FCA Regulation of Fund Advisers
|
Jun 17, 2024 |
|
Culture & Compliance Chronicles: Navigating Corporate Culture and Risk
|
Jun 10, 2024 |
|
SCOTUS and the Future of the Administrative State
|
Jun 06, 2024 |
|
False Claims Act Trends: Q&A with Former DOJ Civil Frauds Attorney and Ropes & Gray Partner Amy Kossak
|
May 30, 2024 |
|
Women @ RopesTalk: Conversation with Svetlana Lucas, Scribe Therapeutics
|
May 22, 2024 |
|
Decoding Digital Health: AI/ML Webinar Recap—U.S. FDA & European Perspectives
|
May 21, 2024 |
|
R&G Tech Studio Presents: Managing Principal and Global Head of Advanced E-Discovery and A.I. Strategy Shannon Capone Kirk
|
May 16, 2024 |
|
Revisiting Pooled Employer Plans (“PEPs”): A Cost-Effective, Low-Risk Solution for Providing Retirement Plan Coverage (Part II)
|
May 13, 2024 |
|
Hazards On—PFAS is Now a Federal Concern
|
May 09, 2024 |
|
Insurance Brokerage M&A: Key Considerations
|
Apr 29, 2024 |
|
Women @ RopesTalk: Conversation with Jill Varner, Versus Capital Advisors
|
Apr 24, 2024 |
|
There Has to Be a Better Way?: Curiosity & Empathy: A Better Way to Approach Data?
|
Apr 19, 2024 |
|
There Has to Be a Better Way?: Data-Powered Insights: Telling Your Risk, Culture, and Ethics Stories with Data
|
Apr 03, 2024 |
|
2024 U.S. Health Care Fraud, Waste & Abuse Trends (Part III): Enforcement Actions
|
Apr 02, 2024 |
|
California Law for Asset Managers: California ESG Landscape
|
Apr 01, 2024 |
|
Women @ RopesTalk: Conversation with Morgan (Dean) O'Neill, Sound Point Capital Management
|
Mar 27, 2024 |
|
Alumni @ RopesTalk: Conversation with Eric Yecies, LifeMD
|
Mar 26, 2024 |
|
2024 U.S. Health Care Fraud, Waste & Abuse Trends (Part II): Guidance on Clinical Laboratory Arrangements
|
Mar 26, 2024 |
|
There Has to Be a Better Way?: Faith@Work: A Personal Conversation on Ethics and Compliance
|
Mar 20, 2024 |
|
2024 U.S. Health Care Fraud, Waste & Abuse Trends (Part I): Advisory Opinions on Patient Inducements
|
Mar 19, 2024 |
|
A Word for Our Sponsors: Contours of a Good Compensation Plan
|
Mar 08, 2024 |
|
Controlling Opinions: Current Developments in Cannabis Research
|
Mar 07, 2024 |
|
There Has to Be a Better Way?: Transforming Compliance Education
|
Mar 06, 2024 |
|
Non-binding Guidance: Preview of the Second Annual Ropes & Gray Rare Disease Forum
|
Feb 29, 2024 |
|
Women @ RopesTalk: Conversation with Jenny Walsh, Sixth Street
|
Feb 22, 2024 |
|
There Has to Be a Better Way?: Understanding the World of Environmental Crimes
|
Feb 21, 2024 |
|
There Has to Be a Better Way?: Reimagining Compliance Training
|
Feb 07, 2024 |
|
Fully Invested: What to Know About Private Equity Operating Companies
|
Feb 06, 2024 |
|
Asset Management Transatlantic Regulatory Roundup: Rules, Culture, Valuations & ESG
|
Feb 06, 2024 |
|
Non-binding Guidance: U.S. Life Sciences Regulatory and Compliance Outlook 2024 (Part IV): Digital Health
|
Jan 31, 2024 |
|
R&G Tech Studio Presents: Ed Black as Technology Strategy Leader
|
Jan 30, 2024 |
|
Insights from OIG’s Strategic Plan for Oversight of Managed Care (Part II)
|
Jan 30, 2024 |
|
The Data Day: Protecting Your Company and Your Data in the Wake of a Cyber Incident
|
Jan 26, 2024 |
|
Non-binding Guidance: U.S. Life Sciences Regulatory and Compliance Outlook 2024 (Part III): Advertising and Promotion
|
Jan 25, 2024 |
|
Talkin’ Trade: Third-Party Subpoenas in ITC Section 337 Proceedings
|
Jan 24, 2024 |
|
There Has to Be a Better Way?: What’s Wrong With Doing the Right Thing?
|
Jan 24, 2024 |
|
Non-binding Guidance: U.S. Life Sciences Outlook 2024 (Part II): Product Development and Pricing
|
Jan 22, 2024 |
|
Revisiting Pooled Employer Plans (“PEPs”): A Cost-Effective, Low-Risk Solution for Providing Retirement Plan Coverage (Part I)
|
Jan 22, 2024 |
|
Non-binding Guidance: U.S. Life Sciences Regulatory and Compliance Outlook 2024 (Part I): FDA Enforcement and Litigation
|
Jan 17, 2024 |
|
Insights from OIG’s Strategic Plan for Oversight of Managed Care (Part I)
|
Jan 16, 2024 |
|
A Word for Our Sponsors: A Conversation with Vikrant Raina of BV Investment Partners
|
Jan 11, 2024 |
|
There Has to Be a Better Way?: 2024 Outlook: What the New Year Brings for Business, Ethics, and Compliance
|
Jan 10, 2024 |
|
New California Climate Disclosure Requirements and Their Relevance to Asset Managers and their Portfolio Companies
|
Dec 19, 2023 |
|
Women @ RopesTalk: Conversation with Marjorie Goux, Rodan & Fields
|
Dec 14, 2023 |
|
There Has to Be a Better Way?: A Year of “Better Ways?”
|
Dec 13, 2023 |
|
Alumni @ RopesTalk: Conversation with George Kopcsay, Atlas Air
|
Dec 12, 2023 |
|
Overview of New California Law Requiring Disclosure on Diversity in VC Investments by “Venture Capital Companies”
|
Dec 05, 2023 |
|
Rated Note Fund Structures: The Impact of the NAIC’s SSAP 26
|
Nov 30, 2023 |
|
There Has to Be a Better Way?: What is the “Right Thing” to Do?
|
Nov 29, 2023 |
|
Controlling Opinions: Introducing Ropes & Gray’s Controlled Substances Compliance Update
|
Nov 20, 2023 |
|
The Data Day: Data Protection Laws in India—A Conversation with Sajai Singh of J. Sagar Associates
|
Nov 16, 2023 |
|
Recent Trends & Developments in Health Care Joint Ventures: Different Joint Venture Models
|
Nov 16, 2023 |
|
Non-binding Guidance: FDA’s Draft Guidance on Communication of Scientific Information on Unapproved Uses of Medical Products
|
Nov 14, 2023 |
|
There Has to Be a Better Way?: Compliance Stories: Lessons Learned in the Field
|
Nov 08, 2023 |
|
R&G Tech Studio Presents: Litigation & Enforcement Partner Helen Gugel
|
Nov 07, 2023 |
|
Recent Trends & Developments in Health Care Joint Ventures: Payor/Provider and Provider/Provider Joint Ventures
|
Nov 02, 2023 |
|
Non-binding Guidance: FDA’s Proposed Rule on Laboratory Developed Tests
|
Oct 30, 2023 |
|
There Has to Be a Better Way?: An Outsider with an Inside View: Researcher Daniel Beunza “Taking the Floor” on Wall Street
|
Oct 25, 2023 |
|
Recent Trends & Developments in Health Care Joint Ventures: Nonprofit/For-Profit Joint Ventures
|
Oct 19, 2023 |
|
A Word for Our Sponsors: Philanthropy & Giving Strategies by Fund Sponsors
|
Oct 18, 2023 |
|
There Has to Be a Better Way?: Not All AI is Generative: AI Strategist and Best-Selling Author Shannon Kirk on the Power of Metrics and Words
|
Oct 11, 2023 |
|
Evolution in Real Estate Joint Ventures
|
Oct 10, 2023 |
|
Recent Trends & Developments in Health Care Joint Ventures: Five Key Considerations for a Successful Joint Venture
|
Oct 05, 2023 |
|
There Has to Be a Better Way?: Playing in the Sandbox with Bots: Nitish Upadhyaya Discusses the Role of the Human in an Increasingly Artificial World
|
Sep 27, 2023 |
|
A Word for Our Sponsors: A Conversation with Kase Jubboori of Bain Capital
|
Sep 26, 2023 |
|
R&G Tech Studio Presents: Data, Privacy & Cybersecurity Co-Leader Rohan Massey
|
Sep 25, 2023 |
|
Recent Trends & Developments in Health Care Joint Ventures
|
Sep 21, 2023 |
|
Women @ RopesTalk: Conversation with Kelly Gold, CAMP4 Therapeutics
|
Sep 19, 2023 |
|
There Has to Be a Better Way?: Is Transparency in Business the Key to Halting Human Trafficking? A Conversation with Actor and Activist Julia Ormond
|
Sep 13, 2023 |
|
Commercial Real Estate Joint Ventures and Funds: What’s the Difference?
|
Sep 12, 2023 |
|
The Inevitable Rise of NAV Financing
|
Sep 08, 2023 |
|
Activism for Non-Activists
|
Sep 07, 2023 |
|
Carbon Talk: An Introduction to the Global Carbon Markets
|
Sep 06, 2023 |
|
California Law for Asset Managers: California Fee Disclosure Law
|
Aug 24, 2023 |
|
R&G Tech Studio Presents: Mergers & Acquisitions Partner Sarah Young
|
Aug 24, 2023 |
|
There Has to Be a Better Way?: Company Leaders First: Former Coach Kevin Espinoza on How to Better Integrate Compliance Within Businesses
|
Aug 23, 2023 |
|
The Sponsor’s Edge: Insights on Growth and Venture Investing—Alternatives to Down Rounds and Bridging Valuation Gaps (Part II)
|
Aug 17, 2023 |
|
Talkin' Trade: Early Off-Ramps from ITC Section 337 Investigations?
|
Aug 17, 2023 |
|
California Law for Asset Managers: An Overview of Lobbying Laws Applicable to Soliciting California Pension Plans and Retirement Systems
|
Aug 10, 2023 |
|
There Has to Be a Better Way?: What Pop Culture Gets Wrong: Leading AI Ethicist Rumman Chowdhury Defines the Real Risks of Artificial Intelligence
|
Aug 09, 2023 |
|
The Sponsor's Edge: Insights on Growth and Venture Investing ”Alternatives to Down Rounds and Bridging Valuation Gaps (Part I)
|
Aug 07, 2023 |
|
Practical Considerations for At-Home Care Post-PHE
|
Jul 27, 2023 |
|
There Has to Be a Better Way?: Do Consumers Care About Corporate Compliance? New Research Says Yes
|
Jul 26, 2023 |
|
Women @ RopesTalk: Conversation with Jennifer Zachary, Merck
|
Jul 25, 2023 |
|
Using the COSO Internal Control Framework for Sustainability Reporting
|
Jul 20, 2023 |
|
Operational Due Diligence: Considerations for Investors
|
Jul 19, 2023 |
|
Non-binding Guidance: Introducing the U.S. Medical Device Recalls Resource Manual
|
Jul 17, 2023 |
|
Talkin' Trade: Trade Secrets, False Advertising, Antitrust, Oh My! — Non-Statutory Claims at the ITC
|
Jul 17, 2023 |
|
Value-based Care Collides with Competition: Antitrust and Enforcement Considerations
|
Jul 13, 2023 |
|
There Has to Be a Better Way?: A Beautiful Association: Antoine Ferrère of Novartis Discusses the Link Between Psychological Safety and Compliance
|
Jul 13, 2023 |
|
Value-based Care Collides with Competition: Deal Impacts for MSOs/DSOs
|
Jun 29, 2023 |
|
Digital Assets Discussion: Consequences of the Proposed Safeguarding Rule for Crypto Asset Custody
|
Jun 28, 2023 |
|
There Has to Be a Better Way?: The Power of Pause: A Retrospective on the Last Six Months
|
Jun 28, 2023 |
|
Alumni @ RopesTalk: Conversation with Heidy King-Jones
|
Jun 27, 2023 |
|
R&G Tech Studio Presents: IP Transactions & Technology Counsel Emily Karlberg
|
Jun 27, 2023 |
|
Women @ RopesTalk: Conversation with Jennifer Chun Barry, Meta
|
Jun 21, 2023 |
|
Value-based Care Collides with Competition: Deal Impacts for Private Equity Companies
|
Jun 15, 2023 |
|
There Has to Be a Better Way?: Miracle on the Hill: How to Build Consensus and Achieve Results in Divided Organizations
|
Jun 14, 2023 |
|
Treacherous Shoals—Navigating Growing Anti-ESG Sentiment: Recent Developments Impacting Asset Managers
|
Jun 08, 2023 |
|
Value-based Care Collides with Competition: Recent Developments on the East Coast
|
Jun 01, 2023 |
|
There Has to Be a Better Way?: GE’s Global Investigations Chief Counsel Katy Choo Discusses the Art of Investigations
|
May 31, 2023 |
|
Why Conduct a GP-Led Secondary?
|
May 23, 2023 |
|
The Applicability of the SEC’s Proposed Custody Rule to Real Estate
|
May 22, 2023 |
|
R&G Tech Studio Presents: Strategic Transactions Co-Leader Marko Zatylny
|
May 18, 2023 |
|
Value-based Care Collides with Competition: Recent Developments on the West Coast
|
May 18, 2023 |
|
There Has to Be a Better Way?: Compliance Leader and Ex-Marine Patrick McGowan Digs Into the Predictive Power of Data Analytics
|
May 17, 2023 |
|
Non-binding Guidance: Recent Developments in Oncology Drug Development
|
May 10, 2023 |
|
Value-based Care Collides with Competition
|
May 04, 2023 |
|
There Has to Be a Better Way?: Part II: Award-Winning Author Benjamin van Rooij Offers a Practical Framework for How Organizations and Lawmakers Can Improve Human Conduct
|
May 03, 2023 |
|
R&G Tech Studio Presents: Litigation & Enforcement Partner Ama Adams
|
May 02, 2023 |
|
Current Topics for Corporates Trading Derivatives
|
May 02, 2023 |
|
Women @ RopesTalk: Conversation with Karna Nisewaner, Cadence Design Systems
|
Apr 26, 2023 |
|
The Data Day: Tracking Cybercriminals and Nation-State Actors in the World of Cryptocurrency—A Conversation with Jackie Koven of Chainalysis
|
Apr 25, 2023 |
|
There Has to Be a Better Way?: Part I: Award-Winning Author Benjamin van Rooij Explains Why Understanding Human Behavior is Essential to Law and Compliance
|
Apr 19, 2023 |
|
R&G Tech Studio Presents: Intellectual Property Litigation Partner Andrew Radsch
|
Apr 18, 2023 |
|
2023 Real Estate Market Outlook
|
Apr 10, 2023 |
|
DOJ’s Withdrawal of Policy Statements Relating to Antitrust Enforcement in Healthcare Markets
|
Apr 06, 2023 |
|
There Has to Be a Better Way?: Not All Messaging Apps Are Ephemeral
|
Apr 05, 2023 |
|
R&G Tech Studio Presents: IP Transactions and Technology Co-Leader Megan Baca
|
Apr 04, 2023 |
|
There Has to Be a Better Way?: Skin in the Game? Dr. Caitlin Handron Discusses How Compliance Incentives Might Work in Practice
|
Mar 29, 2023 |
|
Contingent Dislocation Funds: Nimble Structures Built for Market Events
|
Mar 23, 2023 |
|
There Has to Be a Better Way?: Assumptions v. Research: Unpacking Recent DOJ Policy Initiatives
|
Mar 22, 2023 |
|
R&G Tech Studio Presents: TMT "Dealmaker of the Year" Mike Roh
|
Mar 21, 2023 |
|
There Has to Be a Better Way?: Award-Winning Data Journalist David Yanofsky Explains How to Tell Stories from Data and Why Precision Matters
|
Mar 15, 2023 |
|
R&G Tech Studio Presents: Intellectual Property Litigation Chair Steve Pepe
|
Mar 08, 2023 |
|
Alumni @ RopesTalk: Conversation with Beibei Sun, Sanofi
|
Mar 06, 2023 |
|
The Data Day: A Deeper Look Into the California Consumer Privacy Act (CCPA) & California Privacy Rights Act (CPRA)
|
Mar 02, 2023 |
|
Women @ RopesTalk: Conversation with Siobhan Pomeroy, Gilead Sciences
|
Mar 02, 2023 |
|
U.S. Life Sciences Outlook 2023 (Part IV): Additional Insights on Expected Developments
|
Mar 01, 2023 |
|
There Has to Be a Better Way?: Attorney-Turned-Journalist Megan Zwiebel Talks About the Power of Stories and the Art of Persuasion
|
Mar 01, 2023 |
|
Rated Note Feeder Structures: 2023 Update
|
Feb 27, 2023 |
|
U.S. Life Sciences Outlook 2023 (Part III): Agency Litigation Challenges
|
Feb 27, 2023 |
|
U.S. Life Sciences Outlook 2023 (Part II): Anticipated Agency Policy Developments
|
Feb 23, 2023 |
|
Private Fund Regulatory Update: Recent Developments Regarding the Marketing Rule FAQ, SEC’s Rulemaking Agenda and 2023 Exam Priorities
|
Feb 22, 2023 |
|
U.S. Life Sciences Regulatory Outlook 2023 (Part I): 2022 Trends Expected to Continue Into 2023
|
Feb 21, 2023 |
|
There Has to Be a Better Way?: Dr. Caitlin Handron, Senior Consultant and Behavioral Scientist at R&G Insights Lab, Discusses the Role of Cultural Psychology in Solving Complex Organizational Challenges
|
Feb 15, 2023 |
|
Talkin' Trade: How to “Fix” Section 337 and the ITC
|
Feb 07, 2023 |
|
There Has to Be a Better Way?: Hui Chen, R&G Insights Lab Senior Advisor, Describes Her Atypical Career Path and How It Enriches Her Compliance Insights
|
Feb 01, 2023 |
|
Driving a Successful GP-LP Relationship
|
Jan 31, 2023 |
|
The Data Day: World Data Protection Day and 2023 Trends & Hot Topics
|
Jan 30, 2023 |
|
There Has to Be a Better Way?: Zach Coseglia, Inspiration Junkie and R&G Insights Lab Founder, Describes the Journey to Combine a Data-Driven and Human-Centered Approach to Solving Problems
|
Jan 18, 2023 |
|
Decoding Digital Health: Trans-Atlantic Transfers of Health Data
|
Jan 12, 2023 |
|
R&G Tech Studio Presents: Energy & Infrastructure Co-Leader Taylor Hart
|
Dec 29, 2022 |
|
R&G Tech Studio Presents: IP Transactions and Technology Associate Josh Jackson
|
Dec 28, 2022 |
|
R&G Tech Studio Presents: Asset Management Counsel Ed Baer
|
Dec 23, 2022 |
|
Having Decided to Rebalance a PE Portfolio—Now What? Considerations for LPs Contemplating a Secondary Sale
|
Dec 20, 2022 |
|
Antitrust and Health Care Enforcers Announce Collaboration
|
Dec 19, 2022 |
|
R&G Tech Studio Presents: Data, Privacy & Cybersecurity Partner Fran Faircloth
|
Dec 19, 2022 |
|
The DOL’s Latest Guidance on ESG Investing and Proxy Voting—Key Implications for Plan Fiduciaries
|
Dec 16, 2022 |
|
R&G Tech Studio Presents: Data, Privacy & Cybersecurity Co-Leader Ed McNicholas
|
Dec 13, 2022 |
|
Non-binding Guidance: The Regulatory Landscape for Drug Compounding—10 Years After the NECC Outbreak
|
Dec 05, 2022 |
|
Can Agencies Do That? Limits to Executive Action Regarding Drug Pricing
|
Dec 01, 2022 |
|
R&G Tech Studio Presents: IP Transactions and Technology Partner Regina Sam Penti
|
Nov 30, 2022 |
|
Talkin’ Trade: Examining the Interplay Between the ITC and District Courts
|
Nov 29, 2022 |
|
Non-binding Guidance: Key Takeaways from FDA’s Final Guidance on Clinical Decision Support Software
|
Nov 21, 2022 |
|
Women @ RopesTalk: Conversation with Lisa Mango, One Medical
|
Nov 17, 2022 |
|
FinCEN’s Beneficial Ownership Reporting Requirements: Key Takeaways and Open Questions
|
Nov 16, 2022 |
|
Medicare Rules: Promoting Competition?
|
Nov 15, 2022 |
|
R&G Tech Studio Presents: Venture Capital & Emerging Companies Co-Leader Brad Flint
|
Nov 15, 2022 |
|
Digital Assets Discussion: Implications of Ooki DAO CFTC Enforcement Action
|
Nov 14, 2022 |
|
Decoding Digital Health: Digital Health Dealmaking with John Vaughan, Verily Life Sciences (Part II)
|
Nov 09, 2022 |
|
R&G Tech Studio Presents: Private Equity Partner Scott Abramowitz
|
Nov 02, 2022 |
|
Decoding Digital Health: Digital Health Dealmaking with John Vaughan, Verily Life Sciences (Part I)
|
Oct 26, 2022 |
|
Credit Facilities for Registered Investment Funds
|
Oct 20, 2022 |
|
Women @ RopesTalk: Conversation with Christina Carlson, HI-Bio
|
Oct 19, 2022 |
|
Recent Legal Trends in Restrictive Covenant Enforcement and What Employers Should Know
|
Oct 18, 2022 |
|
Non-binding Guidance: Continued Global Pressure on Drug Pricing & Reimbursement and the Next Frontiers for Effective Market Access
|
Oct 13, 2022 |
|
ESG and the State Coffers: An Emerging Political Battleground
|
Oct 11, 2022 |
|
Fully Invested: SEC Requests
|
Sep 13, 2022 |
|
Talkin' Trade: All About Ancillary Proceedings
|
Sep 06, 2022 |
|
Alumni @ RopesTalk: Conversation with Erin Abood, Stanford University
|
Aug 30, 2022 |
|
Fully Invested: Private Credit Funds
|
Aug 09, 2022 |
|
Fully Invested: Fund of Funds
|
Jul 26, 2022 |
|
Women @ RopesTalk: Conversation with Mallory Capasso, Luxury Brand Partners
|
Jul 20, 2022 |
|
Fully Invested: Derivatives Trading Agreements
|
Jul 12, 2022 |
|
Digital Assets Discussion: Crypto Special Situations and Dislocation Funds
|
Jul 08, 2022 |
|
Recent ETF Developments: Cryptocurrency ETFs and ETPs
|
Jul 07, 2022 |
|
Fully Invested: Form ADV
|
Jun 28, 2022 |
|
ERISA 401(k)/403(b) Fiduciary Developments: The Grab Bag Episode
|
Jun 23, 2022 |
|
Digital Assets Discussion: Stablecoins
|
Jun 22, 2022 |
|
Women @ RopesTalk: Conversation with Katerina Novak, Viking Global Investors
|
Jun 22, 2022 |
|
Fully Invested: Retailization of Private Fund Products
|
Jun 17, 2022 |
|
Recent ETF Developments: Wrappers, Conversions and Exams
|
Jun 16, 2022 |
|
Pre-Approval of Liquidity Opportunities
|
Jun 13, 2022 |
|
Fully Invested: Co-Investments
|
Jun 08, 2022 |
|
Non-binding Guidance: A Recall Readiness Rundown and Recent FDA Actions
|
May 19, 2022 |
|
On the Ropes: Enforcement Risk Roundtable: Argentina’s Foreign Exchange Controls and the Regulatory Risk to Companies in Argentina
|
May 18, 2022 |
|
Impacts of the Russia/Ukraine Conflict on ETFs
|
May 13, 2022 |
|
Co-Investments and Fund Recapitalizations
|
May 03, 2022 |
|
Talkin' Trade: Enforcement of Section 337 Exclusion Orders at U.S. Customs and Border Protection
|
Apr 07, 2022 |
|
A Primer on Asset-backed Leverage Facilities
|
Mar 31, 2022 |
|
Non-binding Guidance: Real-World Evidence in Drug Development
|
Mar 30, 2022 |
|
A Primer on Fund Recapitalizations
|
Mar 30, 2022 |
|
ERISA Litigation Update: Revisiting Northwestern University and Intel
|
Mar 24, 2022 |
|
Women @ RopesTalk: Conversation with Jennifer Wilen, Bombas
|
Mar 24, 2022 |
|
On the Ropes: Enforcement Risk Roundtable: Anti-Corruption and International Risk Perspectives from Recent Developments in Sweden
|
Mar 15, 2022 |
|
Recent Developments on the Use of MAC Clauses In Secondary Transactions
|
Mar 03, 2022 |
|
Alumni @ RopesTalk: Conversation with Ryan Dickey, DOJ & GW Law
|
Mar 03, 2022 |
|
Talkin' Trade: The Powerful General Exclusion Order
|
Feb 23, 2022 |
|
Women @ RopesTalk: Conversation with Adela Cepeda (Mercer Funds) & Susan Rhee (Jackson National Asset Management)
|
Feb 16, 2022 |
|
On the Ropes: Enforcement Risk Roundtable: Anti-Corruption and International Risk Perspectives from Recent Developments in France
|
Feb 15, 2022 |
|
Private Fund Regulatory Update: Recent Developments Regarding Management Fee Calculation and Electronic Communications
|
Jan 24, 2022 |
|
Women @ RopesTalk: Conversation with Ingrid Zhang, Novartis Pharmaceuticals
|
Jan 19, 2022 |
|
How Would an ESG-Friendly DOL Final Rule Change the Investment Marketplace for ERISA Plans?
|
Jan 18, 2022 |
|
Perspectives on the 2021 Secondaries Market and What May Lie Ahead in 2022
|
Jan 12, 2022 |
|
Non-binding Guidance: Recent Developments in FDA Inspection Policy and Implications for Drug and Device Manufacturers
|
Jan 06, 2022 |
|
Talkin' Trade: What Remedies Can The International Trade Commission Impose?
|
Jan 05, 2022 |
|
The Rise of ESG-linked Debt
|
Dec 16, 2021 |
|
Women @ RopesTalk: Conversation with Anne Garcia, The Ohio State University
|
Dec 01, 2021 |
|
Talkin' Trade: Who’s Adjudicating Section 337 Investigations?
|
Nov 30, 2021 |
|
The DOL’s About-face on ESG for ERISA Plan Fiduciary Investment Decision-making
|
Nov 22, 2021 |
|
Health Care Compliance Check-up: Belgium
|
Nov 18, 2021 |
|
Non-binding Guidance: Rolling Back the Medicare Coverage of Innovative Technology (MCIT) Rule
|
Nov 08, 2021 |
|
Talkin’ Trade: When Section 101 Meets Section 337
|
Oct 25, 2021 |
|
Alumni @ RopesTalk: Conversation with Julie Constable, Blackstone
|
Oct 20, 2021 |
|
Health Care Compliance Check-up: Mexico
|
Oct 18, 2021 |
|
Decoding Digital Health: Recent Developments in AI and Machine Learning for Life Sciences and Health Care
|
Oct 12, 2021 |
|
Compliance & Risk Management: Conversation with Jerry Kral, Brown-Forman
|
Oct 08, 2021 |
|
Women @ RopesTalk: Conversation with Kim McCaslin, Bain Capital
|
Oct 05, 2021 |
|
Recent ERISA Litigation Trends & Outcomes
|
Sep 22, 2021 |
|
Non-binding Guidance: FDA’s Intended Use Final Rule
|
Sep 21, 2021 |
|
Health Care Compliance Check-up: Netherlands
|
Sep 08, 2021 |
|
Talkin' Trade: The Interplay Between the ITC and the PTAB
|
Sep 01, 2021 |
|
Conductive Discussions: Patent Eligibility Under Section 101
|
Aug 12, 2021 |
|
Fraud in the Subscription Facility Market: Lenders’ Response
|
Aug 11, 2021 |
|
Health Care Compliance Check-up: Brazil
|
Aug 05, 2021 |
|
Fundraising Update: Secondaries Funds
|
Aug 04, 2021 |
|
Non-binding Guidance: COVID-19 Vaccine Mandate Litigation
|
Jul 29, 2021 |
|
The U.S. Supreme Court Agrees to Hear the Northwestern University Retirement Plan Fee Lawsuit
|
Jul 23, 2021 |
|
Talkin' Trade: IMPORTant Information!
|
Jul 22, 2021 |
|
Women @ RopesTalk: Conversation with Cari Robinson, Revlon
|
Jul 21, 2021 |
|
Life Sciences Real Estate Market Trends: Conversation with Joe Marconi, Bain Capital Real Estate
|
Jul 09, 2021 |
|
Health Care Compliance Check-up: Czech Republic
|
Jul 01, 2021 |
|
Conductive Discussions: Arbitration—Customizable Dispute Resolution
|
Jun 29, 2021 |
|
Pooled Employer Plans (“PEPs”)—An Outsourcing Opportunity for Small and Larger Employers as well as Private Equity Sponsors to Reduce their ERISA Fiduciary Responsibilities
|
Jun 25, 2021 |
|
Navigating the “New Normal” for Security-Based Swaps: Buy-Side Considerations for the SEC’s Security-Based Swap Rules
|
Jun 17, 2021 |
|
Women @ RopesTalk: Conversation with Cris Rothfuss, Sarepta Therapeutics
|
Jun 16, 2021 |
|
Talkin' Trade: Demystifying the Domestic Industry Requirement
|
Jun 15, 2021 |
|
Rated Note Feeder Structures
|
Jun 07, 2021 |
|
Non-binding Guidance: The Defense Production Act and the COVID-19 Pandemic
|
May 27, 2021 |
|
Digital Assets: An Emerging Opportunity for Registered Funds
|
May 25, 2021 |
|
Decoding Digital Health: 2021 Developing Trends and Hot Topics in Digital Health
|
May 19, 2021 |
|
Talkin' Trade: Introduction to Section 337 and the ITC
|
May 18, 2021 |
|
The Rise of ESG ETFs
|
May 13, 2021 |
|
Women @ RopesTalk: Conversation with Tamarah Belczyk, Audax Group
|
May 12, 2021 |
|
The DOL’s Cybersecurity Guidance for Retirement Plan Sponsors, Service Providers and Participants
|
May 11, 2021 |
|
Conductive Discussions: Cybersecurity Threats to the Chip Industry
|
May 10, 2021 |
|
Co-Investments in the Age of Fund Recapitalizations
|
May 07, 2021 |
|
LIBOR Cessation Update
|
May 06, 2021 |
|
Non-binding Guidance: European Life Sciences Regulatory Trends with Dr. Lincoln Tsang
|
Apr 28, 2021 |
|
Data, Privacy and Cybersecurity Under the Biden-Harris Administration
|
Apr 22, 2021 |
|
On the Ropes: Enforcement Risk Roundtable: Anti-Corruption and International Risk Perspectives from Recent Developments in Poland
|
Apr 15, 2021 |
|
On the Ropes: Enforcement Risk Roundtable: Anti-Corruption and International Risk Perspectives from Recent Developments in Poland
|
Apr 15, 2021 |
|
Anderson v. Intel—A Test Case Regarding the Prudence of Adding Alternative Investments to Defined Contribution Plan Menus
|
Apr 15, 2021 |
|
Private Fund Regulatory Update: 2021 SEC Enforcement Priorities
|
Apr 14, 2021 |
|
Conductive Discussions: CFIUS, Trade Regulations, and the Impact on the Semiconductor Industry
|
Apr 13, 2021 |
|
Fraud in the Subscription Facility Market: Will Anything Change?
|
Apr 13, 2021 |
|
Women @ RopesTalk: Conversation with Shana Cappell, PepsiCo
|
Apr 13, 2021 |
|
Creating a Competitive Advantage Through Long-Term Ownership
|
Apr 07, 2021 |
|
Do Fund Sponsors Need a Secondary Buyer for a Fund Recap?
|
Apr 06, 2021 |
|
2021 DOJ Enforcement Priorities Under U.S. Attorney General Merrick Garland
|
Mar 26, 2021 |
|
Recent Developments in European Restructuring Regimes
|
Mar 26, 2021 |
|
CMMI Program Delays and Suspensions—Recommended Next Steps
|
Mar 18, 2021 |
|
The Evolving Regulatory Landscape for ERISA Plan Fiduciaries—Cybersecurity Concerns for Plan Sponsors
|
Mar 16, 2021 |
|
Conductive Discussions: Patent Infringement Under 271(g)—Tips, Traps, and Trends
|
Mar 15, 2021 |
|
On the Ropes: Enforcement Risk Roundtable: Anti-Corruption Developments in Ghana
|
Mar 10, 2021 |
|
Non-binding Guidance: FDA Regulatory Developments in AI and Machine Learning
|
Mar 03, 2021 |
|
Conductive Discussions: Trade Secret Theft—Trends, Remedies, and Trolls, Oh My!
|
Feb 17, 2021 |
|
Considerations for Potential New Entrants into the ETF Market
|
Feb 16, 2021 |
|
Communist Chinese Military Companies Executive Order: Implications and Key Questions
|
Feb 11, 2021 |
|
The Evolving Regulatory Landscape for ERISA Plan Fiduciaries—The Biden Administration & ESG and Proxy Voting Rules
|
Feb 09, 2021 |
|
Newly-Finalized ECI Withholding Regulations: Implications for the Secondaries Market in 2021
|
Feb 09, 2021 |
|
Operating Under the ETF Rule: How Are Things Going in the Early Days?
|
Feb 01, 2021 |
|
Culture & Compliance Chronicles: Compliance Analytics Simplified (A Chat with Integrity Tech Leaders from Lextegrity, Part II)
|
Jan 27, 2021 |
|
2020 Secondary Market in Review
|
Jan 25, 2021 |
|
Women @ RopesTalk: Conversation with Jane Appleby, Advocate Aurora Health
|
Jan 19, 2021 |
|
2021 Global Anti-Corruption Update
|
Jan 14, 2021 |
|
Recent Trends in COVID-19 Employment Litigation
|
Jan 13, 2021 |
|
Pandemic Fundraising Insights and What Lies Ahead for Private Equity in 2021: Conversation with Tom Burger, Gridiron Capital
|
Jan 07, 2021 |
|
End of Life Fund Issues
|
Jan 06, 2021 |
|
Mutual Fund to ETF Conversion
|
Jan 05, 2021 |
|
ESG: Integrating EU and DOL Requirements
|
Dec 16, 2020 |
|
Fund-of-Funds Final Rule & Its Impact on ETFs
|
Dec 15, 2020 |
|
Recent FCA Statement on GDPR Compliance
|
Dec 14, 2020 |
|
Alumni @ RopesTalk: Conversation with Jacob Comer, NovaQuest Capital Management
|
Dec 14, 2020 |
|
Rep and Warranty Insurance in the Context of Fund Recapitalizations: Considerations for Both Fund Sponsors and Investors
|
Dec 10, 2020 |
|
Culture & Compliance Chronicles: Compliance Analytics Simplified (A Chat with Integrity Tech Leaders from Lextegrity, Part I)
|
Dec 01, 2020 |
|
Women @ RopesTalk: Conversation with Ilana Kukoff, Cognition Builders
|
Nov 18, 2020 |
|
What's Happening Now: Current Developments for ETFs as the ETF Rule’s Compliance Date Approaches
|
Nov 11, 2020 |
|
Single Asset Recapitalizations: Considerations for Both Fund Sponsors and Investors
|
Nov 09, 2020 |
|
Cryptocurrency Custody Considerations
|
Nov 02, 2020 |
|
Women @ RopesTalk: Conversation with Louise Dumican, The Carlyle Group
|
Oct 14, 2020 |
|
SEC Updates to the Accredited Investor and Qualified Institutional Buyer Definitions
|
Oct 06, 2020 |
|
On the Ropes: Enforcement Risk Roundtable: Introduction
|
Oct 06, 2020 |
|
Non-binding Guidance: Real-World Evidence in Drug Development and the Impact of the COVID-19 Pandemic
|
Sep 30, 2020 |
|
Credit Funds: Operating Side-by-Side Open- and Closed-End Private Fund Structures
|
Sep 16, 2020 |
|
Culture & Compliance Chronicles: Using Data Ethically
|
Sep 14, 2020 |
|
Culture & Compliance Chronicles: Navigating Data Privacy
|
Aug 25, 2020 |
|
Credit Funds: Fundraising and Restructuring in the COVID-19 Environment: U.S. v. Europe
|
Aug 20, 2020 |
|
CFIUS Considerations for Credit Funds
|
Aug 13, 2020 |
|
Culture & Compliance Chronicles: Techniques on Approaching & Establishing Relationships
|
Aug 06, 2020 |
|
U.S. Anti-Money Laundering Compliance Considerations for Fund Sponsors
|
Aug 05, 2020 |
|
ICI Memo: LIBOR Update – SEC OCIE Issues Risk Alert on LIBOR Transition Preparedness
|
Aug 03, 2020 |
|
Introduction to Gender-Lens Investing
|
Jul 30, 2020 |
|
Rethinking the “S” in ESG in Light of the COVID-19 Pandemic
|
Jul 23, 2020 |
|
SEC Issues Risk Alert: Compliance Issues for Investment Advisers Managing Private Funds – What You Need to Know
|
Jul 22, 2020 |
|
Non-binding Guidance: FDA Regulation of COVID-19 Diagnostic Tests and “Return to Work”
|
Jul 21, 2020 |
|
Market Declines and Falling Out of Carry: Considerations for Fund Sponsors and Investors
|
Jul 17, 2020 |
|
Culture & Compliance Chronicles: Building Relationships & Making Connections
|
Jul 16, 2020 |
|
Insiders' Perspectives on the Ins and Outs of the 2020 DOJ FCPA Guide: A Conversation with Ropes & Gray’s Anti-Corruption and International Risk Leaders
|
Jul 15, 2020 |
|
Culture & Compliance Chronicles: Effective Remediation
|
Jul 01, 2020 |
|
Culture & Compliance Chronicles: Measuring Culture
|
Jun 15, 2020 |
|
Global Health Care Compliance Initiative: Managing Compliance Issues and Process Changes Related to COVID-19
|
Jun 04, 2020 |
|
Alumni @ RopesTalk: Conversation with Jason Idilbi, Passport
|
Jun 03, 2020 |
|
Culture & Compliance Chronicles: Culture in Times of Crisis
|
Jun 01, 2020 |
|
ESG Considerations for Asset Managers in Light of the COVID-19 Pandemic
|
May 18, 2020 |
|
Credit Funds: Considerations for Credit Fund Managers Overseeing ERISA Plan Assets in Light of the COVID-19 Pandemic
|
May 13, 2020 |
|
The Intersection of Private and Registered Funds: Interval Fund Investments in Private Open-End Real Estate Funds
|
May 12, 2020 |
|
Preferred Equity Financings: Tools for Both Fund Sponsors and Investors
|
May 07, 2020 |
|
Building a Sanctions Compliance Programme
|
Apr 28, 2020 |
|
Culture & Compliance Chronicles: Incorporating Behavioral Science in Audit & Monitoring
|
Apr 28, 2020 |
|
Proposed Amendments to the Volcker Rule's Covered Fund Provisions
|
Apr 27, 2020 |
|
TALF 2.0: Anticipating the 2020 Term Asset-Backed Securities Loan Facility Program
|
Apr 20, 2020 |
|
Recent Developments in Credit Funds Secondaries: Has the COVID-19 Pandemic Introduced New Opportunities?
|
Apr 15, 2020 |
|
Culture & Compliance Chronicles: Behavioral Science—The Audit & Monitoring Perspective
|
Apr 02, 2020 |
|
Key Decisions for Defined Contribution Plan Sponsors Under the CARES Act
|
Apr 01, 2020 |
|
Cross-selling in the Crosshairs: Implications and Challenges of the Oracle 401(k) Fee Litigation Settlement
|
Mar 23, 2020 |
|
Alumni @ RopesTalk: Conversation with Alex Roberts, UNH Law
|
Mar 18, 2020 |
|
COVID-19 and Derivatives Trading Agreements: Considerations for the Buy-Side
|
Mar 16, 2020 |
|
CFIUS Update: Key Takeaways from the FIRRMA Implementing Regulations
|
Mar 05, 2020 |
|
ACES Compliance Summit: Conversation with Momentum Events
|
Feb 14, 2020 |
|
Alumni @ RopesTalk: Conversation with Jennifer Bealer, Progyny
|
Feb 12, 2020 |
|
Questions & Concerns About Documentation: A Conversation with Colin Adams, M3 Partners
|
Feb 12, 2020 |
|
ESMA Report: Undue Pressure on Companies
|
Jan 27, 2020 |
|
Non-binding Guidance: SEC Disclosure Issues for Life Sciences Companies
|
Jan 09, 2020 |
|
CFTC Issues LIBOR Transition Relief for Swaps
|
Jan 06, 2020 |
|
Culture & Compliance Chronicles: Applying Behavioral Science to Compliance—A Conversation with Richard Bistrong, Front-Line Anti-Bribery LLC
|
Dec 18, 2019 |
|
ERISA Plan Fiduciaries’ Proxy Voting: Regulatory Updates
|
Dec 16, 2019 |
|
CFIUS: Recent Regulatory Developments
|
Dec 02, 2019 |
|
Supreme Court May Resolve Key ERISA Statute of Limitations and Proprietary Fund Litigation Questions
|
Nov 25, 2019 |
|
Credit Funds: Hot Topics in BDC Regulation
|
Nov 18, 2019 |
|
Key ESG Considerations for Family Offices and Foundations
|
Nov 18, 2019 |
|
Credit Funds: Compliance Considerations for Valuation
|
Nov 13, 2019 |
|
Non-binding Guidance: A Discussion of Kisor v. Wilkie
|
Nov 12, 2019 |
|
Credit Funds: Credit Default Swaps in the Distressed Limelight
|
Nov 11, 2019 |
|
Private Funds Update: The UK Stewardship Code 2020
|
Nov 11, 2019 |
|
Alumni @ RopesTalk: Conversation with Sabrina Ross, Uber
|
Oct 25, 2019 |
|
Fund Subscription Facilities: Key Considerations for Limited Partners
|
Sep 24, 2019 |
|
Asset Management Regulatory Update: Reg BI, Form CRS, and SEC’s Fiduciary Duty Interpretation
|
Sep 19, 2019 |
|
Non-binding Guidance: Breakthrough Devices Program
|
Sep 12, 2019 |
|
Non-binding Guidance: Expedited Review Programs for Drugs and Biologics
|
Sep 05, 2019 |
|
Federal Court Rejects Mutual Fund Fee Claims and Recognizes Market Realities
|
Sep 04, 2019 |
|
Non-binding Guidance: Real-World Evidence in Drug Development and FDA Submissions
|
Aug 12, 2019 |
|
Private Fund Regulatory Update: Network and Cloud Storage
|
Jul 22, 2019 |
|
European Green Finance and Sustainability Proposals: Impact for Asset Managers
|
Jul 18, 2019 |
|
Non-binding Guidance: Examining FDA’s Enforcement Authority Over Stem Cell Clinics and Compounders
|
Jun 28, 2019 |
|
Alumni @ RopesTalk: Conversation with Jeff Gleason, Delaware North
|
Jun 18, 2019 |
|
Credit Funds: Replacing LIBOR – Steps To Consider Taking Now
|
Jun 10, 2019 |
|
The PEP Talk: General Solicitation by Private Equity Funds Under 506(c)
|
Jun 03, 2019 |
|
International Finance Corporation (IFC) Impact Investing Standards
|
May 22, 2019 |
|
ERISA Plan Sponsors, ESG and the April 2019 Executive Order on Promoting Energy Infrastructure
|
May 10, 2019 |
|
Non-binding Guidance: Former FDA Commissioner Scott Gottlieb’s Unfinished Business
|
May 02, 2019 |
|
Credit Funds: 1940 Act Interval Funds
|
May 01, 2019 |
|
Non-binding Guidance: FDA’s Regulation of Products Containing CBD
|
Mar 29, 2019 |
|
Private Fund Regulatory Update: Post-U.S. Government Shutdown
|
Mar 19, 2019 |
|
Conductive Discussions: Recent FRAND & Trade Secret Enforcement Trends Affecting the Semiconductor Industry
|
Jan 24, 2019 |
|
Keeping Up with Recent Changes and Trends in Private Fund Regulation
|
Jan 17, 2019 |
|
Introduction to Credit Funds: Basics on How Credit Funds and Private Equity Funds Differ
|
Sep 27, 2018 |
|
Credit Funds: The Benefits, Challenges and Applications of Treaty Fund Structures When Investing in Credit
|
Sep 20, 2018 |
|
International Risks Facing Latin America Companies
|
Aug 13, 2018 |
|
Common Risks and Challenges in Running a Global Ethics & Compliance Program
|
Jun 19, 2018 |
|
Credit Funds: What Managers Need to Know and Practical Tips to Avoid Insider Trading Risks
|
Jun 05, 2018 |
|
Credit Funds: How PE Funds Can Address and Minimize Conflict When Expanding Into Credit
|
May 01, 2018 |
|
Risk Management: Troubleshooting & Problem Solving
|
Apr 23, 2018 |
|
New Unrelated Business Taxable Income Liability for Providing Certain Fringe Benefits
|
Apr 19, 2018 |
|
Developments in FDA & DOJ Regulation and Enforcement of Manufacturer Communications
|
Apr 12, 2018 |
|
Risk Management: Bringing a Compliance Program to Life
|
Apr 10, 2018 |
|
Credit Funds: A Framework for Addressing and Mitigating Conflicts of Interest
|
Feb 28, 2018 |
|
Credit Funds: How Managers Can Avoid and Mitigate ERISA Conflicts
|
Jan 08, 2018 |
|
Supreme Court Ruling: Impression Products v. Lexmark International
|
Jun 30, 2017 |
|
Shrink the Section 457A Tax on Hedge Fund Management and Incentive Fees and Expand Your Impact
|
May 24, 2017 |
|
Supreme Court Argument: Impression Products v. Lexmark International
|
May 12, 2017 |
|
Supreme Court Ruling: Star Athletica v. Varsity Brands
|
Mar 29, 2017 |
|
Supreme Court Preview: TC Heartland v. Kraft
|
Mar 22, 2017 |
|
FDA Issues Three Key Documents Relating to Manufacturer Communications
|
Jan 31, 2017 |
|
Outlook 2017: The New Administration and Changes in the Federal Judiciary
|
Jan 27, 2017 |
|
Outlook 2017: Administrative Levers and Mechanisms for Policy Change
|
Jan 27, 2017 |
|
The New HHS: Tom Price and Value-Based Healthcare
|
Dec 20, 2016 |
|
The New FDA: Product Development, Pricing and Beyond
|
Dec 20, 2016 |
|
Enforcement Trends: Health Care Enforcement and False Claims Act
|
Dec 19, 2016 |
|
21st Century Cures Act: Provisions Relating to Digital Health
|
Dec 13, 2016 |
|
FDA Holds Public Hearing on Manufacturer Communication of Scientific and Medical Information
|
Nov 14, 2016 |
|
Digital Health Pulse: Regulatory and Transactional Developments
|
Aug 16, 2016 |